However, non-diabetic patients do not face the hypoglycemia risk that diabetics encounter, meaning they can use these medications without the same blood sugar monitoring requirements
This implementation corrects that unauthorized coverage." [2] This means: Even if you had an approved PA before August 31 , it became invalid on that date You now pay 100% out of pocket for Wegovy, Zepbound, Saxenda, Qsymia, Phentermine, and Contrave if prescribed for weight loss No grandfathering the change applied immediately to all TFL beneficiaries What's Still Covered for TFL Diabetes Indication Still Covered GLP-1s prescribed for Type 2 diabetes (Ozempic, Mounjaro, Victoza) remain covered for TFL beneficiaries with prior authorization
Initial blood tests typically include thyroid function tests (TSH, free T4, and sometimes T3), thyroid receptor antibodies (TRAb) where autoimmune disease is suspected, full blood count, renal and liver function, glucose, and lipid profile
No matter what kind of policy you need, you can find an option when you use Insurdinary
Sometimes, reducing the dose or spacing out the timing of the medication can make a big difference in comfort levels
Do your manuals, protocols, and checklists align with the forthcoming changes, including federal and state regulatory expectations
